期刊文献+

转录因子FoxO1在食管鳞癌组织中的表达及其临床意义 被引量:4

Expression and clinical significance of transcription factor FoxO1 in human esophageal squamous carcinoma
下载PDF
导出
摘要 目的检测FoxO1在食管鳞状细胞癌组织中的表达水平,分析其与食管鳞状细胞癌各临床病理因素的关系。方法应用实时荧光定量PCR SYBR Green荧光染料法,检测42例手术切除的食管鳞癌组织及配对的正常食管黏膜组织中FoxO1 mRNA的表达;免疫组化S-P法检测FoxO1蛋白的表达及组织学定位。结果正常食管黏膜组织中FoxO1mRNA及蛋白均呈低表达,而食管鳞癌组织中FoxO1 mRNA及蛋白表达显著升高(P<0.01)。高分化食管鳞癌组织的相对表达量显著高于中低分化食管鳞癌组织(P<0.01)。食管鳞癌组织中FoxO1 mRNA及蛋白表达与患者性别、年龄、肿瘤发生部位、TNM分期及有无淋巴结转移无明显相关性(P>0.05)。结论 FoxO1在正常食管黏膜组织和食管鳞癌组织中的表达存在明显差异,其表达水平与肿瘤分化程度密切相关。 Objective To determine the expression of transcription factor FoxO1,and its correlations to the clinicopathological features of esophageal squamous cell carcinoma(ESCC).Methods SYBR green real-time fluorescent quantitative reverse transcriptase PCR was used to detect the expression levels of FoxO1 mRNA in 42 matched pairs of ESCC tissues and normal samples.The protein expression and location of FoxO1 were measured by immunohistochemistry(SP method).The expression was analyzed with gender,age,site,TNM stage,lymphatic metastasis,and tumor cell differentiation.Results The expression of FoxO1 at mRNA or protein levels was upregulated significantly in ESCC tissues compared with normal esophageal epithelium tissues(P0.01).The expression of FoxO1 was higher in well differentiated ESCC than in poorly differentiated ESCC and normal esophageal epithelium tissues(P0.01).However,the expression of FoxO1 was not correlated to clinicopathological characters,such as gender,age,tumor site,TNM stage,lymphatic metastases and tumor cell differentiation(P0.05).The protein expression of FoxO1 was consistent with that of its mRNA expression.Conclusion The expression of FoxO1 varies significantly in ESCC and normal esophageal epithelium tissues.Over-expression of FoxO1 is closely related to the differentiation of ESCC.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2012年第7期662-665,共4页 Journal of Third Military Medical University
关键词 FOXO1 食管鳞癌 实时荧光定量PCR 免疫组化 FoxO1 esophageal squamous cell carcinoma real-time quantitative RT-PCR immunohistochemistry
  • 相关文献

参考文献11

  • 1Anderson M J,Viars C S,Czekay S,et al.Cloning and characteriza-tion of three human forkhead genes that comprise an FKHR-like genesubfamily[J].Genomics,1998,47(2):187-199.
  • 2Kang S,Xu H,Duan X,et al.PCD1,a novel gene containing PDZand LIM domains,is overexpressed in several human cancers[J].Cancer Res,2000,60(18):5296-5302.
  • 3Kaestner K H,Knochel W,Martnez D E.Unified nomenclature for thewinged helix/forkhead transcription factors[J].Genes Dev,2000,14(2):142-146.
  • 4Greer E L,Brunet A.FOXO transcription factors at the interface be-tween longevity and tumor suppression[J].Oncogene,2005,24(50):7410-7425.
  • 5Medema R H,Jaattela M.Cytosolic FoxO1:alive and killing[J].NatCell Biol,2010,12(7):642-643.
  • 6Guttilla I K,White B A.Coordinate regulation of FOXO1 by miR-27a,miR-96,and miR-182 in breast cancer cells[J].J Biol Chem,2009,284(35):23204-23216.
  • 7Myatt S S,Wang J,Monteiro L J et al.Repression of FOXO1 expres-sion by microRNAs in endometrial cancer[J].Cancer,2010,70(1):367-377.
  • 8颜亚晖,钱燕春.乳腺癌组织中FOXO1蛋白表达与细胞增殖和细胞凋亡的相关性[J].中国组织化学与细胞化学杂志,2010,19(4):380-384. 被引量:5
  • 9周英姿,张友元,桂律,罗金芳.FOXO1A及FLASH在胃癌组织中的表达及其意义[J].肿瘤防治研究,2010,37(6):675-678. 被引量:9
  • 10卢忠燕,甘立霞,缪洪明,王喆,邹全明.FOXO1在胰岛β细胞中的表达及对增殖凋亡功能的影响[J].中国生物化学与分子生物学报,2009,25(1):50-56. 被引量:11

二级参考文献37

  • 1Ling Yang.Incidence and mortality of gastric cancer in China[J].World Journal of Gastroenterology,2006,12(1):17-20. 被引量:345
  • 2甘立霞.FoxO转录因子在代谢调节及肿瘤抑制中的作用[J].第三军医大学学报,2006,28(12):1347-1350. 被引量:7
  • 3李养军,惠延年.高糖诱导牛视网膜微血管周细胞FOXO1A表达增加[J].国际眼科杂志,2007,7(2):373-376. 被引量:4
  • 4Accili D. Lilly lecture 2003: the struggle for mastery in insulin action: from triumvirate to republic [J]. Diabetes, 2004,53(7): 1633-1642
  • 5Zhang W, Feng D, Li Y, et al. PERK EIF2AK3 control of pancreatic beta cell differentiation and proliferation is required for postnatal glucose homeostasis [ J ]. Cell Metab, 2006, 4 (6) : 491-497
  • 6Matveyenko A V, Butler P C. Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes [ J ]. Diabetes, 2006, 55(7):2106-2114
  • 7Butler A E, Janson J, Bonner-Weir S, et al. β-cell deficit and increased β-cell apoptosis in humans with type 2 dabetes [ J ]. Diabetes,2003,52( 1 ) : 102-110
  • 8Sakuraba H, Mizukami H, Yagihashi N, et al. Reduced β-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type 2 diabetes patients [ J ]. Diabetologia, 2002,45 ( 1 ) : 85- 96
  • 9Robertson R P, Harmon J, Tran P O, et al. β Cell glucose toxicity, lipotoxicity and chronic oxidative stress in type 2 diabets [ J ]. Diabetes, 2004,53 ( Suppl 1 ) : s119-124
  • 10Valenti L, Rametta R, Dongiovanni P, et al. Increased expression and activity of the transcription factor FOXOI in nonalcoholic steatohepatitis[J]. Diabetes, 2008, 57(5) : 1355-1362

共引文献20

同被引文献74

  • 1张红梅,胡丽珍,徐佳美,骆芬霞,雷小华,王永钧.慢性肾病患者的盐敏感性及限盐干预的临床研究[J].中国中西医结合肾病杂志,2005,6(5):274-277. 被引量:7
  • 2张诗武,郭华,张丹芳,赵秀兰,谷彦军,孙保存.恶性黑色素瘤血管生成拟态的形态学观察[J].中国肿瘤临床,2005,32(23):1329-1332. 被引量:9
  • 3张士虎,苗毅.胃旁路术对糖尿病大鼠的降糖作用及其机制[J].中华实验外科杂志,2006,23(8):997-999. 被引量:20
  • 4Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med, 2010, 362(12) : 1090 -1101.
  • 5Detournay B, Cros S, Charbonnel B, et al. Managing type 2 diabetes in France : the ECODIA survey[ J ]. Diabetes Metab, 2000, 26 (5) : 363 - 369.
  • 6Pories W J, Flickinger E G, Meelheim D, et al. The effectiveness of gastric bypass over gastric partition in morbid obesity: consequence of distal gastric and duodenal exclusion [ J ]. Ann Surg, 1982, 196 ( 4 ) : 389 - 399.
  • 7Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery : systematic review and meta-analysis [ J ]. Am J Med, 2009, 122(3) : 248 -256.
  • 8Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non- obese animal model of type 2 diabetes: a new perspective for an old disease [J]. Ann Surg, 2004, 239(1) : 1 -11.
  • 9Pontiroli A E, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery, a systematic review and meta-analysis of trials performed with gastric banding and gastric bypass [ J ]. Ann Surg, 2011,253(3) : 484 -487.
  • 10Couzin J. Medicine. Bypassing medicine to treat diabetes[J]. Science, 2008, 320(5875) : 438 -440.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部